Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis
Author:
Peter H. Howarth,Martin A. Stern,Larry Roi,Robert Reynolds,Jean Bousquet
Publication:
Journal of Allergy and Clinical Immunology
Copyright © 1999 Mosby, Inc. All rights reserved.